Literature DB >> 27966794

Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?

Hamed Mirzaei1, Amirhossein Sahebkar2, Mahmoud Reza Jaafari3, Mohammad Goodarzi4, Hamid Reza Mirzaei5.   

Abstract

Exosomes have emerged as one of the main players in intercellular communication. These small nano-sized particles have many roles in various physiological pathways in normal and abnormal cells. Exosomes can carry various cargos such as proteins, mRNAs, and miRNAs to recipient cells. Uptake of exosomes and their cargo can induce and/or inhibit different cellular and molecular pathways that lead to the alteration of cell behavior. Multiple lines of evidence have indicated that exosomes released from cancer cells can effect development of cancer in different stages. These particles and their cargo could regulate different processes such as tumor growth, metastasis, drug resistance, angiogenesis, and immune system functioning. It has been observed that exosomes can be used as potential diagnostic biomarkers in various cancer types. Moreover, some studies have used these particles as biological vehicles for delivery of various drugs such as doxorubicin, siRNAs, and miRNAs. Here, we summarized the findings on the role of exosomes in different pathological processes involved in cancer. Moreover, application of these particles as diagnostic and therapeutic biomarkers in different types of cancers is discussed. J. Cell. Physiol. 232: 3251-3260, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27966794     DOI: 10.1002/jcp.25739

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

Review 1.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

Review 2.  Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy.

Authors:  Ahmed Elsherbini; Erhard Bieberich
Journal:  Adv Cancer Res       Date:  2018-06-09       Impact factor: 6.242

Review 3.  Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.

Authors:  Rajendra Awasthi; Michael John Rathbone; Philip Michael Hansbro; Mary Bebawy; Kamal Dua
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 4.  Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature.

Authors:  Katsutoshi Shoda; Ryo Saito; Suguru Maruyama; Shinji Furuya; Hidenori Akaike; Yoshihiko Kawaguchi; Hidetake Amemiya; Hiromichi Kawaida; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  Surg Today       Date:  2020-09-26       Impact factor: 2.549

Review 5.  Tumor-derived exosomes, microRNAs, and cancer immune suppression.

Authors:  Michael W Graner; Sathya Schnell; Michael R Olin
Journal:  Semin Immunopathol       Date:  2018-06-04       Impact factor: 9.623

6.  Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.

Authors:  Ya-Sian Chang; Hsin-Yuan Fang; Yao-Ching Hung; Tao-Wei Ke; Chieh-Min Chang; Ting-Yuan Liu; Yu-Chia Chen; Dy-San Chao; Hsi-Yuan Huang; Jan-Gowth Chang
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-10       Impact factor: 4.553

7.  A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease.

Authors:  Yahui Shen; Lina Wang; Yunhui Wu; Yingwei Ou; Huiyu Lu; Xin Yao
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

Review 8.  Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment.

Authors:  Stuart P Atkinson; Zoraida Andreu; María J Vicent
Journal:  J Pers Med       Date:  2018-01-23

9.  Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma.

Authors:  Ching-Ping Tseng; Kong-Kit Leong; Miaw-Jene Liou; Hsueh-Ling Hsu; Hung-Chih Lin; Yi-An Chen; Jen-Der Lin
Journal:  Oncotarget       Date:  2017-08-24

Review 10.  MicroRNAs as Biomarkers in Colorectal Cancer.

Authors:  Takaaki Masuda; Naoki Hayashi; Yosuke Kuroda; Shuhei Ito; Hidetoshi Eguchi; Koshi Mimori
Journal:  Cancers (Basel)       Date:  2017-09-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.